Built on regenerative
biotechnology.

Designed for veterinary
medicine.

Origins

Vetinél was developed through the regenerative biotechnology expertise of Allegene Pharmalabs, translating decades of biologic research, engineering and manufacturing into advanced technologies designed specifically for veterinary medicine.

Milestones.

Long before the first veterinary platform, scientific research, engineering and biologic innovation established the foundations for what would become Vetinél.

The journey
behind Vétinel.

1999
Cambridge
Research
Research into cell signaling and regenerative biology established the scientific foundations that continue to shape our technologies.
01
12+
Patent
Families
Scientific discovery evolved into proprietary biologic technologies protected by international patent families.
02
2014
Engineered in
Europe
Techhnologies engineered and manufactured for reproducible biologic preparation.
03
20,000ft²
Controlled
Manufacturing
Human-grade manufacturing workflows built around quality, reproducibility and controlled biologic processing.
04
150,000
Clinical
Translation
More than 150,000 regenerative procedures have contributed to the practical experience behind our technologies.
05
Veterinary
Translation
Human regenerative biotechnology adapted specifically for veterinary medicine.
06
Our work in regenerative biology began with fundamental scientific research and continues today through engineering, manufacturing and clinical translation.
25
Years
Every regenerative procedure contributes to a deeper understanding of biologic preparation, consistency and clinical application.
150k+
Applications
Continuous innovation has resulted in a growing portfolio of technologies designed to improve regenerative medicine.
12+
Patents
Behind every platform.
A closer look inside
Allegene Pharmalabs
How we build biologics
Science. Technology.
Manufacturing.
Application.

One solid pathway. From research to veterinary care.

Biology first.

We engineer technologies around biology—not the other way around.

Closed by Design.

Controlled workflows deliver reproducibility, sterility, and consistency.

Built to evolve.

Platforms developed for today’s regenerative therapies and tomorrow’s biologic innovations.